JPMorgan Chase & Co. Sells 23,935 Shares of Stevanato Group S.p.A. (NYSE:STVN)

JPMorgan Chase & Co. lowered its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN) by 78.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 6,458 shares of the company’s stock after selling 23,935 shares during the period. JPMorgan Chase & Co.’s holdings in Stevanato Group were worth $129,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. nVerses Capital LLC bought a new position in Stevanato Group during the third quarter worth $84,000. Hardy Reed LLC raised its stake in Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after buying an additional 840 shares during the last quarter. Lindenwold Advisors INC raised its stake in Stevanato Group by 13.5% during the third quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock worth $239,000 after buying an additional 1,415 shares during the last quarter. Raymond James Trust N.A. raised its stake in Stevanato Group by 22.6% during the third quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock worth $251,000 after buying an additional 2,317 shares during the last quarter. Finally, Captrust Financial Advisors raised its stake in Stevanato Group by 12.7% during the third quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock worth $262,000 after buying an additional 1,480 shares during the last quarter.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Morgan Stanley reissued an “equal weight” rating and set a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Wolfe Research assumed coverage on shares of Stevanato Group in a research note on Friday, December 13th. They set an “outperform” rating and a $28.00 target price for the company. Finally, Bank of America lifted their target price on shares of Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Stevanato Group has an average rating of “Moderate Buy” and a consensus price target of €28.60 ($29.18).

Stevanato Group Trading Up 1.7 %

NYSE:STVN opened at €22.31 ($22.77) on Monday. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $6.76 billion, a price-to-earnings ratio of 47.47, a PEG ratio of 7.42 and a beta of 0.56. The firm has a fifty day simple moving average of €21.73 and a two-hundred day simple moving average of €20.50. Stevanato Group S.p.A. has a 12 month low of €16.56 ($16.90) and a 12 month high of €34.73 ($35.44).

Stevanato Group (NYSE:STVN) last posted its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.12) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.13) by (€0.01) (($0.01)). The company had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.16 earnings per share. Analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.